Tailored exercise interventions to reduce fatigue in cancer survivors: study protocol of a randomized controlled trial

Table 2 Study Time Points

Process, Outcome or Test	Time Point
	Recruitment	Pre-Intervention		Intervention			Post-Intervention		Follow-Up
		Lab Visit		Week (Total = 12)			Lab Visit		Month
		#1	#2	3	6	9	#3	#4	6	12
Informed Consent		×^a
PAR-Q+		×^a
ECG		×^a
Blood Pressure		×^a					×
Resting HR		×^a					×
Participant Information		×
FACIT-F	×		×	×	×	×		×	×	×
ERAS-r			×	×	×	×		×	×	×
FACT-G			×					×
CES-D		×			×		×	×
BPI-sf		×			×		×
SPS		×					×
GLTEQ		×					×		×	×
ISI		×					×
Venous Blood Sample		×					×
Body Mass		×	×				×	×
Stature		×					×
Neuromuscular Familiarization		×
Start of 15-day Actigraphy		×						×
Sleep Diary		×						×
HRV			×					×
Maximal Exercise Test		×					×
DXA			×					×
CSA			×					×
Grip Strength			×					×
Neuromuscular Function			×					×
Intermittent Cycling Test			×					×

^aIndicates that the item is part of the screening process. BPI-sf, Brief Pain Inventory Short Form, CES-D, Center for Epidemiological Studies on Depression Scale; CSA, cross-sectional area; DXA, dual-energy X-ray absorptiometry; ECG, electrocardiogram; ESAS-r, Edmonton Symptom Assessment System (revised version); FACIT-F, Functional Assessment of Chronic Illness Therapy Fatigue Scale; Functional Assessment of Cancer Therapy - General (FACT-G); GLTEQ, Godin Leisure-Time Exercise Questionnaire; HR, heart rate; HRV, heart rate variability; ISI, insomnia severity index; PAR-Q+, Physical Activity Readiness Questionnaire for Everyone; SPS, Social Provision Scale

ISSN: 1471-2407